title: Clinical use of Biken acellular DPT in two-month old infants.
abstract: We have examined the antibody titer and side effects in two-month-old infants (1.5-2.5) who received vaccinations of acellular DPT Combined Vaccine Adsorbed "Biken" Lots 22 and 23. We observed high-antibody titers far in excess of prevention levels. No particular increase in side effects was observed in the two-month-old infants, except a normal increase in once-only side effects. The results suggest that this vaccine can protect infants under one year of age, who are especially liable to be affected by this illness.
authors.affiliation: Department of Pediatrics, Mie National Hospital, Tsu-city Mie Prefecture, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kamiya
authors.forename: R
authors.initials: R
authors.lastname: Nii
authors.forename: T
authors.initials: T
authors.lastname: Matsuda
authors.forename: M
authors.initials: M
authors.lastname: Chazono
authors.forename: I
authors.initials: I
authors.lastname: Yoshida
mesh_terms: D000367:Age Factors; D000907:Antibodies, Bacterial / Q000097:blood; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage* / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D014917:Whooping Cough / Q000517:prevention & control
chemical_list: D000907:Antibodies, Bacterial; D015721:Diphtheria-Tetanus-Pertussis Vaccine